Dara Capital US’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Dara Capital US's NVO Position: Q3 2026 in Review
Dara Capital US held its Novo Nordisk (NVO) position steady in Q3 2026 at 4,630 shares worth $176K. The position accounts for 0.99% of the portfolio, ranked #20.
Dara Capital US first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $236K in Q4 2025. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Dara Capital US held 4,630 shares of Novo Nordisk worth $176K as of Q3 2026.
- Dara Capital US left its Novo Nordisk share count unchanged in Q3 2026.
- Novo Nordisk made up 0.99% of Dara Capital US's portfolio in Q3 2026, its #20 holding.
- Dara Capital US first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
- Dara Capital US's Novo Nordisk position peaked at $236K in Q4 2025.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Dara Capital US's 13F filing for Q3 2026, filed 29 Oct 2026.